InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Uihlein Richard E, Director. Officer active across 1 company, notably Galectin Therapeutics INC. Aggregated, 8 disclosures have been logged. Activity tracked since 24 January 2022. The latest transaction was disclosed on 31 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Uihlein Richard E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,550,932 shares@ US$4.055.29% mcap9.1% of flowCommon StockSEC:0001133416-26-000065:1
31,825,235 shares@ US$3.0048.87% mcap83.8% of flowCommon StockSEC:0001133416-26-000065:0
13,158 shares@ US$3.040.5% of flowCommon StockSEC:0001133416-26-000020:0
32,520 shares@ US$1.230.5% of flowCommon StockSEC:0001133416-25-000022:0
23,256 shares@ US$1.720.5% of flowCommon StockSEC:0001133416-24-000026:0
1,466,204 shares@ US$5.0098.6% of flowCommon StockSEC:0001133416-23-000075:0
36,036 shares@ US$1.110.5% of flowCommon StockSEC:0001133416-23-000008:0
17,677 shares@ US$1.980.4% of flowCommon StockSEC:0001133416-22-000043:0
8 of 8 declarations
About Uihlein Richard E
Richard E. Uihlein is a Director at GALECTIN THERAPEUTICS INC. He brings extensive experience in corporate governance and strategy. As a director, Richard contributes to the direction and oversight of the company's activities, ensuring they align with best practices and strategic objectives. His expertise is a valuable asset for GALECTIN THERAPEUTICS INC.
